Medical device makers set for quicker clearances
The Indian government has proposed amendments to the Medical Devices Rules, 2017, to accelerate the licensing process for manufacturers. The changes aim to reduce approval timelines for various medical devices, including cardiac stents and blood pressure monitors, by up to 25 days.
Why it matters
Streamlining regulatory approvals can reduce costs for manufacturers and improve the availability of essential medical technology in the Indian healthcare market.
NEW DELHI: Manufacturers of blood pressure monitors, cardiac stents, hip and knee implants and other medical devices could soon get regulatory approvals up to 25 days faster, with the Centre proposing changes to streamline the licensing process while retaining existing quality, safety and performance standards. Union health ministry has issued draft amendments to Medical Devices Rules, 2017, proposing to shorten manufacturing licence approval timelines and prescribe fixed timelines for every stage of regulatory scrutiny. The draft notification has been placed in public domain for stakeholder comments. Under the proposal, time taken to grant manufacturing licences for Class B medical devices, including blood pressure monitors, pulse oximeters and hypodermic needles, would be reduced from 140 days to 115 days. For Class C and Class D medical devices, including cardiac stents, hip and knee implants and other orthopaedic implants, the approval timeline would be cut from 105 days to 90 days.Get the latest India news and live updates. Download the TOI App.
The article provides a factual summary of a government policy proposal without editorializing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in